Heart failure & cardiomyopathies
A Multicentre Registry of Hospitalized Patients with Acute and Chronic Heart Failure: Study Design of the H2-Registry
Authors' conclusion
The H2-registry is currently the largest ongoing prospective registry of HF patients in Germany. It is foreseeable that the H2-registry will significantly contribute to the collection of real-world data and provide a comprehensive and unique perspective on the current characteristics, treatment strategies, and resulting outcomes of HF patients in Germany. Trial registration number: NCT04844944.
Study context
- Population
- Inpatients ≥18 years of age with a present diagnosis of chronic or acute heart failure (HF) in secondary and tertiary hospitals throughout Germanyenrolled in 10 study centres until 31 December 2023, 1593 patients with complete follow-up (FU) data for 6- and 12-month outcomes
- Participants
- 2,361 inpatients
- Outcome
- Baseline characteristics
Methodological detailsinterim analysis
- Interim analysis
Main finding
As reported in the abstract
Mean age
72 years
Female
36.9%
Median left ventricular ejection fraction
45%
Observational data: associations, not effects.
Further findings
All-cause mortality · 6 and 12 months
- All-cause mortality at 6 months
- 9.0%
- All-cause mortality at 12 months
- 16.2%
- Cohort of 1593 patients with complete FU data
HF-related rehospitalizations · 6 and 12 months
- HF-related rehospitalizations at 6 months
- 24.4%
- HF-related rehospitalizations at 12 months
- 43.5%
- Cohort of 1593 patients with complete FU data
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →